Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Schedule of Operations by Reportable Segment

Approximate information concerning the Company’s operations by reportable segment for the twelve months ended December 31, 2023 and 2022 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein:

Year Ended December 31, 2023	Product Packaging		Commercial Lending			Direct Marketing			Biotechnology			Securities			Corporate			Total
Revenue	$	18,497,000	$	385,000		$	6,088,000		$	-		$	5,288,000		$	-		$	30,258,000
Assets held for sale		-		-			-			-			51,595,000			-			51,595,000
Depreciation and amortization		761,000		-			157,000			1,163,000			3,047,000			78,000			5,206,000
Cost of revenue		15,282,000		1,139,000			2,075,000			77,000			8,003,000			71,000			26,647,000
Interest expense		185,000		-			(5,000	)		-			4,632,000			-			4,812,000
Interest Income		-		-			986,000			155,000			148,000			-			1,289,000
Stock based compensation		-		-			-			-			-			-			-
Net income (loss) from continuing operations		327,000		(31,497,000	)		(32,860,000	)		(7,168,000	)		(19,792,000	)		(6,513,000	)		(97,503,000	)
Capital expenditures		689,000		-			4,000			17,000			104,000			4,000			818,000
Identifiable assets		21,508,000		12,285,000			6,303,000			49,305,000			59,345,000			4,446,000			153,192,000

Year Ended December 31,2022	Product Packaging			Commercial Lending			Direct			Biotechnology			Securities			Corporate			Total
Revenue	$	17,973,000		$	764,000		$	21,989,000		$	-		$	6,581,000		$	-		$	47,307,000
Depreciation and amortization		715,000			-			413,000			1,113,000			9,093,000			129,000			11,463,000
Cost of revenue		16,960,000			1,041,000			9,828,000			-			11,784,000			634,000			40,247,000
Interest expense		140,000			-			1,000			-			(15,000	)		-			126,000
Stock based compensation		1,000			-			-			-			-			3,000			4,000
Net income (loss) from continuing operations		(1,234,000	)		(459,000	)		(40,182,000	)		(7,462,000	)		(8,238,000	)		(12,084,000	)		(69,662,000	)
Capital expenditures		1,612,000			-			384,000			276,000			18,000			4,000			2,294,000
Identifiable assets		24,641,000			48,240,000			27,526,000			53,069,000			83,873,000			11,566,000			248,915,000

Schedule of Disaggregation of Revenue

Printed Products Revenue Information:

Twelve months ended December 31, 2023
Packaging Printing and Fabrication	$	18,036,000
Commercial and Security Printing		461,000
Total Printed Products	$	18,497,000

Twelve months ended December 31, 2022
Packaging Printing and Fabrication	$	17,499,000
Commercial and Security Printing		474,000
Total Printed Products	$	17,973,000

Direct Marketing

Twelve months ended December 31, 2023
Direct Marketing Internet Sales	$	6,088,000
Total Direct Marketing	$	6,088,000

Twelve months ended December 31, 2022
Direct Marketing Internet Sales	$	21,989,000
Total Direct Marketing	$	21,989,000

Rental Income

Twelve months ended December 31, 2023
Rental income	$	3,647,000
Total Rental Income	$	3,647,000

Twelve months ended December 31, 2022
Rental income	$	6,287,000
Total Rental Income	$	6,287,000

Commission Income

Twelve months ended December 31, 2023
Commission income	$	1,641,000
Total commission income	$	1,641,000

Twelve months ended December 31, 2022
Commission income	$	294,000
Total commission income	$	294,000

Management Fee Income

Twelve months ended December 31, 2023
Management fee income	$	-
Total Management fee income	$	-

Twelve months ended December 31, 2022
Management fee income	$	134,000
Total Management fee income	$	134,000

Net Investment Income

Twelve months ended December 31, 2023
Net investment income	$	385,000
Total Net Investment Income	$	385,000

Twelve months ended December 31, 2022
Net investment income	$	630,000
Total Net Investment Income	$	630,000